Literature DB >> 7852378

Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake.

F M Williams1, W F Flintoff.   

Abstract

A clone has been isolated from a human lymphoblastic cDNA expression library that complements a mutant Chinese hamster cell defective in the uptake of the folate analogue methotrexate. When transfected with this clone the mutant cells regain the ability to transport the drug and, as a consequence, become sensitive to its cytotoxic action. The clone is 2863 base pairs long and has an open reading frame of 1770 base pairs that codes for a putative protein of 64 kDa. The putative protein has 51 and 50% identity at the amino acid level with the mouse and hamster functions, respectively, involved in the transport of reduced folates. Together these three proteins share 47% identity and have similar predicted structural features. The data are consistent with this human clone encoding either the reduced folate transporter or an auxiliary function that interacts with this transporter.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7852378     DOI: 10.1074/jbc.270.7.2987

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Cytoplasmic domains of the reduced folate carrier are essential for trafficking, but not function.

Authors:  Heather Sadlish; Frederick M R Williams; Wayne F Flintoff
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

Review 2.  SLC19: the folate/thiamine transporter family.

Authors:  Vadivel Ganapathy; Sylvia B Smith; Puttur D Prasad
Journal:  Pflugers Arch       Date:  2003-05-06       Impact factor: 3.657

Review 3.  Uptake carriers and oncology drug safety.

Authors:  Jason A Sprowl; Alex Sparreboom
Journal:  Drug Metab Dispos       Date:  2013-12-30       Impact factor: 3.922

4.  Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter.

Authors:  Larry H Matherly; Zhanjun Hou
Journal:  Vitam Horm       Date:  2008       Impact factor: 3.421

5.  SLC19A1 pharmacogenomics summary.

Authors:  Sook Wah Yee; Li Gong; Ilaria Badagnani; Kathleen M Giacomini; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-11       Impact factor: 2.089

Review 6.  The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.

Authors:  Larry H Matherly; Mike R Wilson; Zhanjun Hou
Journal:  Drug Metab Dispos       Date:  2014-01-06       Impact factor: 3.922

7.  Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons.

Authors:  L Zhang; S C Wong; L H Matherly
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

8.  Restoration of high-level transport activity by human reduced folate carrier/ThTr1 thiamine transporter chimaeras: role of the transmembrane domain 6/7 linker region in reduced folate carrier function.

Authors:  Xiang Y Liu; Teah L Witt; Larry H Matherly
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

Review 9.  Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.

Authors:  Zhanjun Hou; Larry H Matherly
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

10.  Characterization of a cysteine-less human reduced folate carrier: localization of a substrate-binding domain by cysteine-scanning mutagenesis and cysteine accessibility methods.

Authors:  Wei Cao; Larry H Matherly
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.